文献速递心脑血管急症

生长分化因子-15预测急性冠脉综合征患者不良心脏事件:一项Meta分析

Growth-differentiation factor-15 predicts adverse cardiac events in patients with acute coronary syndrome: A meta-analysis.
PubMed 文献 · Am J Emerg Med · 2019-04-19
一句话结论Meta分析显示高GDF-15与ACS患者死亡(RR=6.75)和再发心梗(RR=1.95)显著相关,心衰风险分层尚需更多数据。

该Meta分析检索PubMed和EMBASE至2017年12月,纳入13项研究、43547例急性冠脉综合征(ACS)患者,比较高水平与低水平生长分化因子-15(GDF-15)与死亡、再发心梗和心衰的关联。结果显示,高GDF-15与死亡显著相关(p=0.000,RR=6.75,95%CI 5.81-7.84),与再发心梗显著相关(p=0.000,RR=1.95,95%CI 1.72-2.21),亚组分析结果相似。心衰分析存在异质性(I²=87.3%),总RR为6.66。作者认为需更多数据研究ACS患者心衰的风险分层。

要点

  • ACS患者高GDF-15水平与死亡显著相关(p=0.000,RR=6.75,95%CI 5.81-7.84)。
  • ACS患者高GDF-15水平与再发心梗显著相关(p=0.000,RR=1.95,95%CI 1.72-2.21)。
  • 心衰分析总RR为6.66,但异质性I²=87.3%。
  • 共纳入13项研究、43547例ACS患者,亚组分析结果与总体一致。
  • 作者认为未来需更多数据研究ACS患者心衰的风险分层。

适用人群与场景

  • 急性冠脉综合征(ACS)患者,纳入13项研究共43547例参与者。

研究设计与关键结果

  • 研究类型:Meta分析,检索PubMed和EMBASE自建库至2017年12月,纳入13项评估GDF-15与ACS关联的研究,共43547例参与者,采用随机效应模型合并风险比(RR),并进行发表偏倚和敏感性分析。
  • 总体分析显示高GDF-15与死亡显著相关(p=0.000,RR=6.75,95%CI 5.81-7.84),与再发心梗显著相关(p=0.000,RR=1.95,95%CI 1.72-2.21)。
  • 亚组分析显示与总体分析相似的结果。
  • 心衰分析总RR为6.66,异质性I²=87.3%。

证据类型、等级与局限

  • 证据类型:Meta分析。
  • 局限:心衰分析存在异质性(I²=87.3%);作者指出未来需更多数据研究ACS患者心衰的风险分层。

对床旁实践的改变

  • 原文未据此给出推荐;作者认为未来需更多数据研究ACS患者心衰的风险分层。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: We aimed to analyse the association between high-level growth-differentiation factor-15 (GDF-15) and mortality, recurrent MI and heart failure compared to low-level GDF-15 in patients with acute coronary syndrome (ACS).

METHODS: PubMed and EMBASE were searched from their commencement to December 2017 for qualified studies that evaluated the associations between GDF-15 and ACS. Risk ratios were synthesized with random effect meta-analysis. Publication bias and sensitivity analyses were also conducted.

RESULTS: A total of thirteen studies and 43,547 participants were analyzed systematically in our meta-analysis. Our study showed a significant association between GDF-15 values and mortality (p = 0.000, RR = 6.75, 95% CI = 5.81-7.84) and recurrent MI (p = 0.000, RR = 1.95, 95% CI = 1.72-2.21) in the overall analyses. Subgroup analyses revealed similar results. However, there was evidence of heterogeneity in the study of heart failure, whose overall RR was 6.66, with an I2 of 87.3%.

CONCLUSION: There was a significant association between high-level GDF-15 and mortality, recurrent MI in patients with ACS. We need more data to research the risk stratification of heart failure in ACS patients in the future.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Wang Y, Zhen C, Wang R, et al. Growth-differentiation factor-15 predicts adverse cardiac events in patients with acute coronary syndrome: A meta-analysis. Am J Emerg Med. 2019. PMID: 31029521. doi:10.1016/j.ajem.2019.04.035

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。